Concepedia

Daniel Rosik

DR

16

Publications

1.3K

Citations

16

H-Index

2006

Active since

Affiliations

Uppsala University(Current)

KTH Royal Institute of Technology

Affibody (Sweden)

Uppsala University Hospital

AlbaNova

Daniel Rosik is an author at Uppsala University specializing in engineering, molecular imaging, and biomedical imaging.

Top concepts

Publications per year

2006–2020

16

Publications

16

Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule

Vladimir Tolmachev, Anna Orlova, Rikard Pehrson et al. · Cancer Research · 2007 · 217 citations

Design of an Optimized Scaffold for Affibody Molecules

Joachim Feldwisch, Vladimir Tolmachev, Christofer Lendel et al. · Journal of Molecular Biology · 2010 · 175 citations

, , +4

Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount

Vladimir Tolmachev, Daniel Rosik, Helena Wållberg et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 117 citations

, , +12

Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry

Vladimir Tolmachev, Mikaela Friedman, Mattias Sandström et al. · Journal of Nuclear Medicine · 2009 · 112 citations · Full text

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Vladimir Tolmachev, Fredrik Nilsson, Charles Widström et al. · PubMed · 2006 · 111 citations

Rows per page

1–5 of 16